Dhanya Raveendra Panickar

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Sanford Burnham Prebys Medical Discovery Institute, The Salk Institute, Yale University. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dhanya Raveendra Panickar. Retrieved from https://idiyas.com/inventor/dhanya-raveendra-panickar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)

Company Filing History:

3 out of 99

Sanford Burnham Prebys Medical Discovery Institute

Sanford-Burnham Medical Research Institute

patents

5. 1 out of 16,048

University of California

patents

where one patent can have more than one assignee

Years Active: 2014-2020

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10774092 - ULK1 inhibitors and methods using same (2020-09-15),

2. 10689397 - ULK1 inhibitors and methods using same (2020-06-23),

3. 10266549 - ULK1 inhibitors and methods using same (2019-04-23),

4. 8748632 - Positive allosteric modulators of group II mGluRs (2014-06-10),

Title: Dhanya Raveendra Panickar: Innovator in Biological Research

Introduction

Dhanya Raveendra Panickar is a prominent inventor based in La Jolla, CA (US). She has made significant contributions to the field of biological research, particularly in the development of therapeutic methods. With a total of 4 patents, her work focuses on innovative solutions for treating various diseases.

Latest Patents

Among her latest patents is a groundbreaking invention related to ULK1 inhibitors. This invention provides a method for treating a disease or condition in a subject by co-administering a therapeutically effective amount of at least one ULK1-inhibiting pyrimidine alongside an mTOR inhibitor. This dual approach aims to enhance treatment efficacy for patients in need.

Career Highlights

Dhanya has worked at esteemed institutions such as the Salk Institute for Biological Studies and the Sanford Burnham Prebys Medical Discovery Institute. Her experience in these organizations has allowed her to collaborate with leading scientists and contribute to cutting-edge research.

Collaborations

Throughout her career, Dhanya has collaborated with notable colleagues, including Reuben J Shaw and Daniel F Egan. These partnerships have further enriched her research and innovation efforts.

Conclusion

Dhanya Raveendra Panickar is a remarkable inventor whose work in biological research continues to impact the field significantly. Her innovative patents and collaborations highlight her dedication to advancing medical science.

Profile summary based on public USPTO records.